USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market
07-Jun-2019
Asia Pacific
Market Research
PA00-01-00-00-00
HC03171-AP-MR_23119
This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests.
The Asia-Pacific shows the highest prevalence of infectious diseases, such as tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs). Countries such as India, China, and Indonesia are some of the leading contributors to these life-threatening infections. Hence, the Asia-Pacific stands out as a key contributor to the global infectious diseases diagnostics market.
With the rising disease prevalence, companies are shifting their business models to a more consumer-oriented approach. Steps are being taken to ensure a direct contact with the consumer/end user by means of direct-to-consumer selling using ecommerce portals such as Amazon. Alongside retail selling, vendors such as Alibaba ensure a bulk dispatch of diagnostic devices to hospitals and clinics, thereby playing a crucial role in the diagnostic value chain. The study also highlights some of the innovative payment models which result in improved patient access to these high value therapies. Information on some of the emerging business models across the cell therapy market, such as risk sharing, fast to market business models, etc., has also been provided.
Key Features
The study aims to identify some of the key growth opportunities which are set to drive the market in the next few years. It provides a revenue analysis of the total Asia-Pacific infectious diseases POCT market with an analysis of the specific regional players as well as the most common infectious disease diagnostics. The study also highlights some of the key market drivers and restraints which affect the growth. Additionally, it gives an insight on the leading market trends shaping the industry and their long-term implications on market growth. It also focuses on some of the country-specific regulatory policies and their impact on the adoption of innovative diagnostics solutions.
Key Issues Addressed
- What are the biggest opportunities for companies in the infectious disease point-of-care testing space?
- How are the various countries within the Asia-Pacific positioned to monetize the market opportunities?
- What is the total market size and projected growth of POCT solutions for infectious diseases?
- What are the key success factors for companies to remain relevant and competitive in this market?
- How are product offerings in this market likely to emerge? How are transitions taking place across the value chain to solve the unmet needs from customers?
Key Findings
Key Findings (continued)
Executive Summary—Market Engineering Measurements
Scope and Segmentation
Key Questions Addressed in this Study
6 Big Themes for the Infectious Disease POCT Market of the Future
Market Background and Overview
Value Chain Analysis
Value Chain Analysis (continued)
Drivers and Restraints
Technology Trends in the APAC Infectious Diseases POCT Market
Key Trends and Impact on Business
Technology Initiatives for Infectious Disease Diagnosis in APAC
Where is the Market Heading?
Market Analysis
Infectious Diseases Surveillance in APAC
Regional Perspectives for Infectious POCT Market in APAC—Top 5 Countries
Key Healthcare Reforms in China—Timeline
POCT in China—Market Dynamics
POCT in Japan—Market Dynamics
Tuberculosis Programmes in Southeast Asia
Market Engineering Measurements
Revenue Forecast Assumptions
Revenue Forecast
Revenue Forecast Discussion
Market Opportunity by Disease Area
Snapshot of Market Participants
Snapshot of Market Participants (continued)
Market Share Analysis
Key Companies to Watch
Key Companies to Watch (continued)
Competitive Environment
Competitive Factors Assessment
Competitive Benchmarking—POCT Solution Providers
Competitive Benchmarking—POCT Solution Providers (continued)
Key Mergers, Acquisitions, and Partnership Assessment
Visioning Scenarios for the Infectious Disease POCT Market
Business Models–Business to business to consumer (B2B2C) Models
Emerging Business Models—D2B2C* Models
Transformation in Industry Ecosystem
4 Major Growth Opportunities
Growth Opportunity 1—Affordable POC Tuberculosis Diagnostic Kit
Growth Opportunity 2—Growing Prevalence of Anti-microbial Resistance (AMR) Infections
Growth Opportunity 3—Portable Real-time Diagnostic Machines
Growth Opportunity 4—Under-penetrated Indonesian Market
Strategic Imperatives for Success and Growth
The Last Word—Three Big Predictions
Legal Disclaimer
Abbreviations
List of Exhibits
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Key Features
The study aims to identify some of the key growth opportunities which are set to drive the market in the next few years. It provides a revenue analysis of the total Asia-Pacific infectious diseases POCT market with an analysis of the specific regional players as well as the most common infectious disease diagnostics. The study also highlights some of the key market drivers and restraints which affect the growth. Additionally, it gives an insight on the leading market trends shaping the industry and their long-term implications on market growth. It also focuses on some of the country-specific regulatory policies and their impact on the adoption of innovative diagnostics solutions.
Key Issues Addressed
- What are the biggest opportunities for companies in the infectious disease point-of-care testing space?
- How are the various countries within the Asia-Pacific positioned to monetize the market opportunities?
- What is the total market size and projected growth of POCT solutions for infectious diseases?
- What are the key success factors for companies to remain relevant and competitive in this market?
- How are product offerings in this market likely to emerge? How are transitions taking place across the value chain to solve the unmet needs from customers?
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aarti Chitale |
| Industries | Healthcare |
| WIP Number | PA00-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,99C6-B1,9627-B1 |
Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023
$3,000.00
Special Price $2,250.00 save 25 %